ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPK-00455
製品名称
IGF1R/CD221 Protein, Human, Recombinant (His & Avi)
タンパク質名
IGF1R/CD221
Species
Human
HOST
HEK293 Cells
100μg: -
お問い合わせ

Overview

Synonyms MGC142172, IGF-I receptor, IGF-I R, IGF-1R, MGC18216, MGC142170, IGF1R, IGFR, JTK13, IGFIR, CD221
Characteristics Immobilized Human IGF1R, His Tag at 5μg/ml (100μl/well) on the plate. Dose response curve for Human IGFI, hFc Tag with the EC50 of 0.62μg/ml determined by ELISA.
Endotoxin Level < 1 EU/μg by the LAL method.
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC
Description The type 1 IGF receptor (IGF1R) is a transmembrane tyrosine kinase that is frequently overexpressed by tumours, and mediates proliferation and apoptosis protection. IGF signalling also influences hypoxia signalling, protease secretion, tumour cell motility and adhesion, and thus can affect the propensity for invasion and metastasis. Therefore, the IGF1R is now an attractive anti-cancer treatment target. IGF1R/CD221 Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 105.8 kDa (alpha subunit) and 23 kDa (beta subunit) and the accession number is P08069.
Reference Richards DM, et al. HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality. J Immunother Cancer. 2019;7(1):19 Published 2019 Jul 19. doi:10.1186/s40425-019-0671-4
URL https://www.targetmol.com/recombinant-protein/igf1r_cd221_protein_human_recombinant_his_avi_

お問い合わせリスト(-)

お問い合わせフォーム